The research seeks out well being care suppliers’ views on medical hashish

Breadcrumb Trail Links

Health workers in the United States and Canada are encouraged to contribute.

Author of the article:

Angela Stelmakowich Practicing health care providers are asked Practicing health care providers are asked “about their experiences with medical cannabis in their practices, their previous training on the subject, and their interest in future clinical training.” /. Photo by Cameravit / iStock / Getty Images Plus

Article content

Dr. Marion McNabb, President of CCOE, points out that even “the fundamentals of the endocannabinoid system, the benefits and risks of medical cannabis, and approaches to integrating medical cannabis use” are, for most health professionals, cannabis science and not part of the regular curriculum are technology reports. This includes those in medicine, nursing, dentistry, public health, emergency medicine, and addiction and recovery, says Dr. McNabb.

With increasing evidence of the effectiveness of cannabis and its actual use in the treatment of snowballs, “This study seeks from healthcare providers for themselves what they want and want to know about medical cannabis and how its use can be incorporated into their practice. “She adds.

Article content

A research paper published in 2019 found that 58.1 percent of healthcare providers surveyed believe that medical cannabis is a legitimate medical therapy. Nevertheless, “gaps in the knowledge of providers about the efficacy of medical cannabis under state-determined qualification conditions must be closed and precise information about the potential for drug interactions disseminated in order to allay the concerns of the providers,” the authors of the study write.

“This study seeks to hear from healthcare providers for themselves what they know and want to know about medical cannabis and how its use can be incorporated into their practice.” /. Photo by Getty Images

“Standardized education could ensure that health professionals are willing to responsibly promote cannabis use when appropriate for medically appropriate symptoms and conditions,” added another study.

However, there is a lot of catching up to do. As recently as last month, an Israeli study found that medical students there felt unprepared, despite their stronger support for the use of medical cannabis for pain management than their counterparts in Thailand.

In its previous announcement, CCOE reported that the study, which is supported by Super Critical Labs, “has been approved by the UMass Dartmouth Institutional Review Board for research in humans.” The anonymous survey, which will be available from May 5, 2021 to May 5, 2022, will take approximately 12 minutes to complete for healthcare workers.

As the main researcher, Dr. McNabb was accompanied by 15 co-investigators, including “researchers, clinicians and veterans of diverse backgrounds, diversity and expertise,” adds Cannabis Science and Technology.

Preliminary study results are expected to be available in October and updated next May.

Article content

We apologize, but this video could not be loaded.

Subscribe to Weekend Dispensary, a new weekly newsletter from The GrowthOp.

Comments are closed.